If there is one aspect of cranks that is almost universal (besides the aforementioned tendency to want to prove themselves through things like “live televised debates“), it’s a tendency to want to shut down the criticism of its opposition. True, such a tendency is a human trait as well and used far too often by, […]
Category: Clinical trials
About a month ago, Eric Merola screened his second movie about “brave maverick doctor” Stanislaw Burzynski, Burzynski: Cancer Is A Serious Business, Part 2 (henceforth referred to as “Burzynski II”), a screening that Brian Thompson and an unnamed colleague from the James Randi Educational Foundation (JREF) attended, took notes, and even managed to ask a […]
Share this:
If there’s one thing that a certain subset of people who view themselves as reasonable and science-based don’t like, it’s harshness: Harshness in criticism, harshness in discussion, or—horror of horrors!—anything they view as “incivility.” That’s all well and good as far as it goes, but the problem is that sometimes there are things that demand […]
Share this:
One of the more depressing things about getting much more interested in the debate over how we should screen for common cancers, particularly breast and prostate cancer, is my increasing realization of just how little physicians themselves understand about the complexities involved in weighing the value of such tests. It’s become increasingly apparent to me […]
Share this:
I got a bit behind on my work yesterday, so I’ll be brief. Yesterday, the James Randi Educational Foundation (JREF) announced its annual Pigasus Awards. Sadly, each and every year, there are far more “deserving” candidates than there are awards to give. However, this year marks something awesome, namely the first time the prize has […]
